May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
The Surgical Treatment of Neovascular Glaucoma With a 200 Micron Miniature Glaucoma Shunt
Author Affiliations & Notes
  • E. Dahan
    Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa
  • T.R. Carmichael
    Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa
  • Footnotes
    Commercial Relationships  E. Dahan, Optonol Ltd P, R; T.R. Carmichael, None.
  • Footnotes
    Support  Optonol Ltd (supply of Glaucoma Shunts free of charge)
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 77. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Dahan, T.R. Carmichael; The Surgical Treatment of Neovascular Glaucoma With a 200 Micron Miniature Glaucoma Shunt . Invest. Ophthalmol. Vis. Sci. 2005;46(13):77.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To test the 200 micron ExPRESS glaucoma shunt in neovascular glaucoma (NVG). Methods: A prospective non–randomized pilot study was performed on 12 eyes with NVG due to retinal vein occlusion (RVO) or proliferative diabetic retinopathy (PDR). The surgery consisted of implantation of the ExPRESS 200 micron shunt, under a 6x5mm scleral flap. Mitomycin C 0.2% solution was applied on a 5x4mm area of deep sclerectomy under the scleral flap for 3 minutes prior to the insertion of the ExPRESS shunt. Outcome measures included intra–ocular pressure (IOP), number of anti–glaucoma medications and complications. Results: The group included five Caucasian, one Black and one Indian with RVO; three Black and two Indian with PDR. The overall mean (±SD) IOP preoperatively was 48.7 mmHg (±14.9). The IOP was 50.3 mmHg (±13.6) in the 7 patients with RVO and 46.4 mmHg (±17.8) in the 5 patients with PDR. One year post–operatively the overall mean IOP was 23.7 mmHg (±13.1). In the RVO group it was 21.5 mmHg (±12.9) and in the PDR group it was 28.0 mmHg (±15.1). Pre–operatively all the patients used anti–glaucoma medications. At one year, of the nine evaluable cases, none was using anti–glaucoma medications. Complications consisted of failure of surgery due to bleb fibrosis/uncontrolled rubeosis in six cases and postoperative hyphaemas which occurred in four of the five diabetic patients. None required surgery. There were no episodes of post–operative hypotony. Conclusions: The operation was successful (IOP≤21 mmHg without antiglaucoma medications) in five of seven cases with RVO. The surgery was found to be ineffective in PDR patients with four of the five showing progressive disease and uncontrolled IOP.

Keywords: neovascularization • diabetic retinopathy • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×